APA (7th ed.) Citation

Farooq, A., Zulfiqar, B., & Asghar, K. (2022, September). Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma. Journal of Cancer and Allied Specialties.

Chicago Style (17th ed.) Citation

Farooq, Asim, Bilal Zulfiqar, and Kashif Asghar. "Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma." Journal of Cancer and Allied Specialties Sep. 2022.

MLA (9th ed.) Citation

Farooq, Asim, et al. "Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma." Journal of Cancer and Allied Specialties, Sep. 2022.